How to Get GLP-1 Patients as a Psychiatrist in California

You didn’t go through medical school and residency to become a telehealth mill doctor. But here’s the reality: 20 million Americans are now on GLP-1 medications, and most of them can’t find a provider who will prescribe and monitor them properly. Meanwhile, half of your psychiatric colleagues are already prescribing Ozempic or similar drugs — often for patients dealing with medication-induced weight gain.

The opportunity is massive. The question is: how do you tap into this demand without destroying your schedule, compromising care quality, or turning your practice into an assembly line?

This guide walks through exactly how psychiatrists and PMHNPs can build a scalable, profitable GLP-1 practice while maintaining the professional autonomy and work-life balance that drew many of us to telehealth in the first place.

Why Psychiatrists Are Uniquely Positioned for GLP-1 Care

The Patient Demand Reality

GLP-1 usage for weight loss increased roughly 600% over six years through 2024, with about 6% of Americans actively taking these medications by late 2025. That’s not a trend — that’s a fundamental shift in how obesity is treated in this country.

Here’s what matters for your practice: tens of thousands of new patients start GLP-1 treatment every week, and the majority struggle to find providers. Obesity medicine specialists are overwhelmed. Primary care docs are hesitant or don’t have time for the follow-up these patients need. Telehealth-only weight loss clinics are popping up everywhere, but many offer cookie-cutter care with minimal provider interaction.

This creates a gap that psychiatrists can fill — especially those already running efficient telehealth practices.

Your Competitive Advantage

Unlike other specialties jumping into weight loss, you bring something unique: expertise in behavior change and mental health. Weight loss isn’t just about the medication — it’s about sustaining motivation, managing the psychological impact of body image changes, addressing emotional eating patterns, and monitoring for mood effects that other providers might miss.

Many of your existing patients are already perfect candidates. Antipsychotics cause weight gain. Mood stabilizers cause weight gain. Some antidepressants cause weight gain. You’re already having conversations about this, and patients are frustrated. Being able to say ‘I can actually help you with this’ transforms those conversations and deepens therapeutic relationships.

A late-2023 survey found nearly half of psychiatrists in major departments were already prescribing or recommending these medications. The early adopters are seeing the benefit — both clinically and financially.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

The Economics: Cash-Pay vs Insurance

Let’s talk numbers, because this matters for sustainability.

The Cash-Pay Reality

Most GLP-1 weight-loss practices operate primarily on a cash-pay model, and for good reason: insurance coverage for obesity is still limited. As of 2024, only 13 state Medicaid programs covered GLP-1s for weight loss (including California, Pennsylvania, and Illinois). Many private plans exclude obesity drugs entirely or make prior authorization so onerous that patients give up.

This creates a patient population willing to pay out-of-pocket — both for visits and medications. Common models include:

• Per-visit pricing: $100-200 for initial consultation, $75-150 for follow-ups
• Monthly subscription packages: $150-300/month including consultations and care coordination
• Medication cost: Brand-name Wegovy runs $1,300+ without insurance; compounded semaglutide from reputable pharmacies costs $200-400/month

The key advantage of cash-pay: predictable revenue, no prior authorizations, simpler operations. You set your prices based on the value you provide and the time you invest. No fighting with insurance companies about medical necessity.

The Insurance Alternative

Some providers choose to accept insurance for visits while patients pay cash for medications. This widens your patient pool — particularly for people who can afford treatment only if the visit costs are covered.

You can bill standard E/M codes for obesity management or use Medicare’s G0447 code for behavioral counseling. But be prepared for:

• Extensive documentation requirements
• Potential denials (some plans still consider obesity treatment ‘cosmetic’)
• Prior authorization coordination with pharmacies (even though you’re not billing for the meds)
• Lower reimbursement rates that may not reflect the actual time invested

The middle path many psychiatrists choose: hybrid pricing. Charge cash for comprehensive initial evaluations (which insurance barely reimburses anyway), then offer patients the option of using insurance for routine follow-ups if they have good coverage.

State Coverage Trends to Watch

Medicare is piloting weight-loss drug coverage in coming years — if that expands broadly, insurance-based models become more viable. Some states like California, Pennsylvania, and Illinois have moved faster on Medicaid coverage, creating opportunities in those markets for providers who want to accept insurance.

Be transparent with patients upfront about costs. Most appreciate knowing exactly what they’ll pay monthly rather than discovering surprise bills later. This builds trust and reduces no-shows.

Building Scalable Workflows That Don’t Break You

Here’s where most providers fail: they try to scale patient volume using the same workflows that work for 10-20 patients. By patient 50, they’re drowning. By patient 100, they’re burned out.

Scaling a GLP-1 practice requires systematization without depersonalization. Here’s how:

Streamline Intake

Create a comprehensive digital intake form that patients complete before the first visit. This should cover:

• Complete weight history and previous weight loss attempts
• Medical conditions and contraindications (thyroid issues, pancreatitis history, family history of medullary thyroid carcinoma)
• Current medications (especially psychiatric meds contributing to weight gain)
• Mental health screening (depression, anxiety, binge eating patterns)
• Lifestyle factors (diet, exercise, sleep, stress)
• Goals and expectations

This saves 15-20 minutes per initial consultation and ensures you don’t miss critical information. It also demonstrates thoroughness — patients recognize you’re taking this seriously.

Develop standardized order sets for initial labs: A1c, fasting glucose, TSH, comprehensive metabolic panel. One click orders everything. Results come back before the first visit so you’re not wasting appointment time waiting for labs.

Protocol-Driven Care

Create clinical protocols for common scenarios:

• Inclusion criteria: BMI ≥30, or ≥27 with comorbidities (following FDA approval for Wegovy)
• Exclusion criteria: Active thyroid cancer, personal history of medullary thyroid carcinoma, pregnancy/planning pregnancy, severe gastroparesis
• Dose titration schedules: Standard escalation protocols for semaglutide (0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg monthly increases) or tirzepatide
• Side effect management: Templated guidance for nausea (take with food, smaller portions, ginger), constipation, injection site reactions
• Red flags requiring immediate contact: Severe abdominal pain, vision changes, signs of pancreatitis

Having protocols doesn’t mean robotic care — it means you’re not reinventing the wheel for every patient. It frees up mental energy for the complex cases that need your full clinical judgment.

Optimize Follow-Up Frequency

GLP-1 patients need monthly follow-ups during the first 3-6 months while titrating doses and establishing routines. After stabilization, many can extend to every 2-3 months.

Keep these visits focused:

• Current weight and progress toward goals (5-10 minutes)
• Side effect check and management (5 minutes)
• Medication adherence and injection technique (3 minutes)
• Mental health check-in — mood changes, body image concerns, motivation (5-7 minutes)
• Lifestyle coaching or referrals (5 minutes)

A well-structured follow-up takes 15-20 minutes, not 45. Use templates in your EHR for documentation — modify as needed, but don’t start from scratch every time.

Leverage Your Team

You don’t have to do everything yourself. Delegation is critical:

• Medical assistants or RNs can handle intake data collection, weight/BP measurement (via patient self-report for telehealth), preliminary symptom questionnaires, and routine patient portal questions
• Health coaches or dietitians (either on staff or via referral partnerships) can provide weekly or biweekly lifestyle counseling, recipe ideas, exercise guidance — the stuff that takes time but doesn’t require your prescriber license
• Behavioral health therapists can work with patients on emotional eating, body image, or weight loss plateaus

Some practices run monthly group telehealth sessions — a 30-45 minute Zoom where a dietitian or health coach covers nutrition topics, answers common questions, and creates community. This reduces repetitive one-on-one counseling you’d otherwise provide.

The psychiatrist or PMHNP focuses on what only they can do: medical evaluation, prescribing decisions, monitoring for psychiatric effects, and complex clinical judgment.

Technology That Actually Helps

The right tech stack prevents administrative overwhelm:

Essential Tools

• Telehealth platform with integrated EHR: Don’t use separate systems for video visits and documentation. Platforms like Simple Practice, Doxy.me + TherapyNotes, or specialty weight-loss platforms streamline this.
• E-prescribing: Send scripts directly to the patient’s preferred pharmacy (or your partner compounding pharmacy). Avoid phone calls and faxes.
• Automated scheduling and reminders: Patients book their own follow-ups online. Automated SMS/email reminders reduce no-shows by 30-40%.
• Patient portal for asynchronous communication: Patients can message simple questions (‘Can I take this medication with food?’) without requiring a phone call or video visit.

Nice-to-Have Additions

• Remote monitoring: Some practices issue connected scales or use apps where patients log weekly weights. You see trend graphs at a glance during visits instead of asking ‘So, how’s your weight been?’
• Automated education: When you prescribe a new dose, an automated email with dosing instructions, side effect management, and FAQs goes out. Patients get immediate answers without waiting for staff.
• AI documentation assistance: Tools like Abridge or DeepScribe can generate visit notes from your consultation, cutting documentation time from 10 minutes to 2-3 minutes of review/editing.

Technology should reduce friction, not create it. If a tool requires more clicks or adds complexity, skip it.

Preventing Burnout: Setting Boundaries That Stick

The flexibility of telehealth is a double-edged sword. You can see patients from anywhere — but that can quickly become ‘patients expect you to be available everywhere, always.’

Protect Your Schedule

Start conservatively. Don’t go from 0 to 50 GLP-1 patients in a month. Begin with dedicated half-days — maybe Tuesday and Thursday afternoons for weight management patients. This creates boundaries and prevents weight-loss appointments from cannibalizing your entire schedule.

As demand grows and systems prove out, gradually expand. But always maintain buffer time between patients for documentation and breaks. Back-to-back telehealth visits without breaks is a fast track to burnout.

Set Communication Boundaries

Establish specific hours for patient messages and communicate them clearly: ‘I review patient portal messages between 9-11 AM and 3-5 PM on weekdays. Urgent medical issues should go to your PCP or the ER.’

Use auto-responders for after-hours emails. If patients expect immediate responses at 9 PM, they’ll text you at 9 PM. Train them early that you’re available during defined windows.

Consider an answering service for after-hours calls — they can triage true emergencies (which are rare with GLP-1s) versus questions that can wait until morning.

Maintain Professional Variety

Many psychiatrists keep a mixed practice — psychiatric patients and weight-management patients. This adds variety to your day and keeps clinical skills sharp across domains.

Others fully transition to obesity medicine because they find it more rewarding and less emotionally draining than managing severe mental illness. There’s no wrong answer — but staying in your lane by choice, not default, matters for satisfaction.

Monitor Your Own Well-Being

Watch for classic burnout signs:

• Emotional exhaustion (dreading patient visits)
• Depersonalization (viewing patients as tasks, not people)
• Declining work quality (cutting corners on documentation, skipping labs)

If you notice these, immediately reassess your capacity. Options include:

• Temporarily cap new patient intake
• Raise prices (reducing volume, increasing revenue per patient)
• Hire a part-time PMHNP or PA to share the load
• Take a week off to reset

Research shows that greater schedule control and virtual practice flexibility significantly reduce provider burnout. You’re in telehealth specifically for this autonomy — use it.

State-by-State Regulatory Navigation

Telehealth crosses state lines, but regulations don’t. Here’s what matters for the six priority states:

California

Licensure: Full California medical license required (not in Interstate Medical Licensure Compact). PMHNPs must work under physician supervision unless they achieve new independent ‘104 NP’ status (available starting January 2026 after completing 3 years as a supervised ‘103 NP’).

Key rule: Must obtain patient consent for telehealth (verbal or written, documented in chart). No in-person visit required for non-controlled substances.

Insurance landscape: California Medicaid covers GLP-1s for obesity as of 2024, potentially increasing insured patient demand.

Texas

Licensure: Texas license required (Texas is in IMLC for expedited physician licensing). PMHNPs must have a Prescriptive Authority Agreement with a Texas physician — no independent practice.

Key rule: Patient-practitioner relationship can be established via telehealth with adequate audio-visual evaluation (no in-person requirement). One physician can supervise up to 7 APRNs/PAs in Texas.

Practice note: High obesity rates and many underserved rural areas create strong demand. Be prepared for supervision requirements if using NPs.

Florida

Licensure: Full Florida license OR Out-of-State Telehealth Provider Registration (available to out-of-state MDs in good standing). Psychiatric NPs require physician supervision (FL’s autonomous practice law applies only to primary care NPs, not psychiatric NPs).

Key rule: No prior in-person exam required for telehealth. GLP-1s are non-controlled, so out-of-state registered providers can prescribe them freely.

Practice note: Large retirement population seeking health improvement; historically limited insurance coverage means mostly cash-pay market.

New York

Licensure: New York medical license required (not in IMLC). Experienced PMHNPs (≥3,600 hours of practice) can achieve full practice authority and prescribe independently. Newer NPs need physician collaboration agreements.

Key rule: Strong telehealth parity law — insurers must cover telehealth like in-person visits. No unusual teleprescribing restrictions.

Practice note: Huge population in NYC area (competitive) but significant rural provider shortages upstate. Medicaid doesn’t widely cover GLP-1 for obesity yet.

Pennsylvania

Licensure: Pennsylvania license required (PA is in IMLC for expedited physician licensing). PMHNPs must have a Collaborative Agreement with a physician — no independent practice path currently.

Key rule: Adequate patient evaluation required (can be via video). Recently joined Nurse Licensure Compact (2025), potentially easing some multi-state practice for RNs.

Practice note: Pennsylvania Medicaid covers GLP-1 for obesity as of 2024. Mix of urban and rural areas creates diverse patient opportunities.

Illinois

Licensure: Illinois license required (IL is in IMLC). PMHNPs can achieve Full Practice Authority after 4,000 hours of clinical practice + 250 hours additional education — then can prescribe independently.

Key rule: Comprehensive telehealth parity law (2021) requires insurers to cover telehealth services. No in-person exam requirement for non-controlled substances.

Practice note: Illinois Medicaid covers GLP-1 for obesity. FPA pathway makes Illinois attractive for experienced NPs wanting autonomy.

Patient Acquisition: Where the Patients Actually Are

Marketing a GLP-1 practice doesn’t require a huge budget — but it does require clarity about who you serve and what makes you different.

Start Internal

Your existing psychiatric patients are the lowest-hanging fruit. During medication reviews, ask about weight concerns. Many patients on antipsychotics, mood stabilizers, or certain antidepressants struggle with weight gain and would welcome help.

Script: ‘I’ve noticed your weight has increased since starting [medication]. That’s a common side effect. I now offer medical weight management including GLP-1 medications if you’re interested in exploring that. Would you like to discuss options?’

Converting existing patients requires zero marketing spend and builds on established trust.

Platform Partnerships

Joining established telehealth platforms (like Klarity Health) connects you immediately with patient demand. These platforms invest heavily in advertising and patient acquisition, then match qualified patients to providers.

The economics work differently than traditional marketing: instead of spending $3,000-5,000/month on ads with uncertain results, you pay a per-appointment fee only when qualified patients book with you. No upfront marketing spend, no monthly subscriptions, no wasted ad dollars on clicks that don’t convert.

This is particularly valuable when scaling — you control exactly how many appointment slots you open, and you only pay for patients you actually see. The platform handles the expensive patient acquisition work (SEO, Google Ads, patient screening, booking infrastructure), while you focus on delivering care.

Direct Marketing (If You Prefer)

Building your own patient pipeline is possible but requires patience and investment:

• SEO: Create content on your website about GLP-1 and mental health (e.g., ‘Managing Weight Gain from Psychiatric Medications’). This takes 6-12 months of consistent content before generating meaningful patient flow.
• Google Ads: Mental health and weight loss keywords cost $15-40+ per click. Realistic cost per booked patient through PPC: $200-400+. Budget accordingly.
• Directory listings: Psychology Today, Zocdoc, etc. charge monthly fees ($100-300+) AND you compete with hundreds of other providers on the same page.

Reality check: DIY marketing can eventually be cost-effective IF you have the budget ($3K-5K/month minimum), expertise (or hire a healthcare marketing agency), and patience to wait months for results. For most providers, especially those starting out or scaling quickly, platform partnerships offer guaranteed ROI versus gambling on marketing channels.

Referral Relationships

Build connections with:

• Primary care physicians overwhelmed with obesity patients
• Endocrinologists who appreciate psychiatric expertise for patients with co-occurring mood disorders
• Therapists and dietitians who work with emotional eating or weight concerns but can’t prescribe

Brief intro email: ‘I’m a psychiatrist offering medical weight management via telehealth, including GLP-1 medications. I specialize in patients with co-occurring mental health conditions or medication-induced weight gain. Happy to collaborate on shared patients — I’ll keep you updated and refer back for routine medical care.’

Most providers are relieved someone else will handle this aspect of care.

The Bottom Line: Sustainable Growth

The GLP-1 opportunity is real. Patient demand far outpaces provider supply, and psychiatrists bring unique value that generic weight-loss clinics can’t match.

But sustainable growth requires intention:

• Start systematically: Build workflows before scaling volume
• Delegate ruthlessly: You prescribe and handle complex cases; others handle coaching, admin, routine questions
• Use technology wisely: Automate what can be automated; preserve human connection where it matters
• Protect boundaries: Your schedule, your communication windows, your capacity limits
• Choose your business model: Cash-pay for simplicity, insurance for access, or hybrid for flexibility

Done right, a GLP-1 practice enhances both your income and professional satisfaction. You’re solving a real problem for patients who need medical and psychological support — not just a prescription.

The providers who thrive in this space aren’t the ones seeing the most patients. They’re the ones who built systems that scale without sacrificing their own well-being or the quality of care patients deserve.

Ready to add GLP-1 weight management to your psychiatric practice without the operational headaches? Klarity Health connects psychiatrists and PMHNPs with pre-qualified patients seeking comprehensive weight-loss care — you focus on clinical excellence while we handle patient acquisition, scheduling infrastructure, and telehealth technology. Explore joining Klarity’s provider network and start seeing patients on your terms.

FAQ

Can psychiatrists legally prescribe GLP-1 medications for weight loss?

Yes. Psychiatrists (MD/DO) have full prescriptive authority for GLP-1 medications in all states where they hold a medical license. These medications are not controlled substances, so federal Ryan Haight Act restrictions don’t apply. Psychiatric NPs can also prescribe GLP-1s in most states, though some require physician collaboration agreements (Texas, Pennsylvania) while others allow independent practice after meeting experience requirements (New York, Illinois, California by 2026).

Do I need to see GLP-1 patients in person, or can I treat them entirely via telehealth?

Entirely via telehealth is legal and common. Since GLP-1 medications are non-controlled substances, no federal or state law requires an initial in-person visit. You must establish an appropriate patient-practitioner relationship through a comprehensive telehealth evaluation (covering medical history, BMI, contraindications, mental health screening) and meet the same standard of care as in-person treatment. States like Texas, Florida, and California explicitly permit establishing care via synchronous audio-video consultation for non-controlled medications.

How much can I realistically earn from a GLP-1 practice?

Revenue depends on your model. Cash-pay providers typically charge $100-200 for initial consultations and $75-150 for follow-ups. With monthly follow-ups during the first 3-6 months, a patient generates $900-1,800 in visit revenue during that period, then ongoing revenue from quarterly visits. If you see 40 active GLP-1 patients (manageable with efficient workflows), that’s roughly $3,000-6,000 monthly from visits alone. Insurance-based models generate lower per-visit revenue but potentially higher volume. Many providers run hybrid models — cash for initial evals, insurance for follow-ups where coverage exists.

What about malpractice insurance — does this require additional coverage?

Most psychiatrists’ existing malpractice policies cover prescribing medications within their scope of practice, which includes treating obesity (a chronic medical condition). However, notify your insurance carrier that you’re adding weight-management services to ensure coverage. Some carriers may require a rider or slightly higher premiums for prescribing outside traditional psychiatric medications. PMHNPs should verify their policies explicitly cover prescribing for weight loss, especially if working independently in states that allow it.

How do I handle patients who want GLP-1s but don’t meet medical criteria?

Set clear expectations upfront: GLP-1s are FDA-approved for obesity (BMI ≥30) or overweight with comorbidities (BMI ≥27 with conditions like hypertension, diabetes, or dyslipidemia). Patients seeking these medications purely for cosmetic weight loss at normal BMIs don’t meet criteria. Use your intake process to screen for appropriate candidates before scheduling consultations. When patients don’t qualify, explain the medical reasoning and offer alternatives (nutritional counseling, exercise programs, addressing underlying psychiatric conditions like binge eating). Most appreciate honesty over being told yes just to make a sale.

What if a patient experiences mood changes or suicidal thoughts on GLP-1 medication?

This is where your psychiatric expertise becomes invaluable. Early reports suggested possible links between GLP-1s and suicidal ideation, though the FDA’s 2026 review found no clear causal relationship. Regardless, monitor closely: include mood screening at every follow-up (use standardized questions about depression, anxiety, suicidal thoughts). If a patient reports new or worsening psychiatric symptoms, assess severity — mild mood changes might resolve with continued monitoring, but significant depression or suicidal ideation requires immediate intervention (potentially pausing the medication, increasing psychiatric support, or emergency referral). Document thoroughly and treat as you would any medication-induced psychiatric effect.

Can I prescribe compounded semaglutide, or should I stick to brand-name medications?

Both options exist. Brand-name Wegovy (FDA-approved for obesity) costs $1,300+ monthly without insurance — prohibitive for many patients. Compounded semaglutide from licensed compounding pharmacies costs $200-400/month, making treatment accessible to more people. If using compounded medications, ensure your pharmacy partner is properly licensed, uses FDA-compliant ingredients, and follows USP standards. The FDA has issued warnings about unregulated compounders selling questionable products, so vet your pharmacy carefully. Many telehealth practices successfully use reputable compounding pharmacies; just be transparent with patients about the difference between compounded and FDA-approved formulations.

How do I compete with all the telehealth weight-loss startups advertising everywhere?

You don’t compete on advertising budget — you compete on clinical expertise and comprehensive care. Generic telehealth weight-loss mills offer quick prescriptions with minimal follow-up. You offer integrated psychiatric and medical care: addressing emotional eating, monitoring for mood effects, managing medication-induced weight gain, and providing genuine behavior change support. Market this advantage: ‘Psychiatrist-led weight management for people who need more than just a prescription.’ Target patients with co-occurring mental health conditions, those on psychiatric medications, and people who’ve failed cookie-cutter programs. Your competitive advantage isn’t volume — it’s depth of care that produces better long-term outcomes.

Citations

1. Axios (May 27, 2025). ‘Just how many Americans are taking GLP-1s now.’ Retrieved from https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing

2. ConfectioneryNews (October 20, 2025). ‘GLP-1 drugs like Ozempic are reshaping health, diet and the food industry.’ Retrieved from https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry

3. Time Magazine (August 22, 2025). ‘The Heavy Cost of Using Weight-Loss Drugs to Get Skinny.’ Retrieved from https://time.com/7311517/cost-weight-loss-drugs-skinny

4. Axios (May 28, 2024). ‘America’s doctors need more obesity medicine training.’ Retrieved from https://www.axios.com/2024/05/28/us-doctors-obesity-health-care-training

5. Axios (November 5, 2024). ‘States slow to cover GLP-1s for weight loss.’ Retrieved from https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss

Source:

• https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing#:~:text=More%20than%202,their%20original%20approved%20use
• https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/#:~:text=GLP,real%20number%20according%20to%20Kim
• https://forum.schizophrenia.com/t/psychiatrists-recommend-ozempic/311318#:~:text=Drugs%20pharmanewsintel
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=equivalent%20to%20in,FDA%2C%20pharmacy%2C%20and%20board%20alerts
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=,with%20chart%20review%2C%20plus%20meetings
• https://www.singleaimhealth.com/news/nurse-practitioner-collaborative-agreement-templates-50-state-guide#:~:text=In%20Pennsylvania%2C%20Certified%20Registered%20Nurse,the%20CRNP%20and%20the%20collaborating
• https://www.wheel.com/state-telehealth-regulations/florida#:~:text=Are%20There%20Online%20Prescription%20Restrictions,for%20Telehealth%20in%20Florida
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=most%20insurances%20cover%20the%20medication,A%20recent%20Annals%20of%20Internal
• https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss#:~:text=What%20they%20found%3A%20In%20all%2C,a%20primary%20concern%2C%20KFF%20found
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=But%20these%20medications%20were%20originally,diabetes%2C%20weight%20loss%20treatment%20is